Opioids are prescription medicines like codeine, hydrocodone, morphine, oxycodone, fentanyl, and tramadol that are used to treat pain. Opioid-induced constipation is one of the most common side effects of opioid use.1-3
Opioids block pain signals by attaching to something called mu-receptors in the brain and other parts of the central nervous system. However, opioids also attach to mu-receptors in the bowel, which can cause opioid-induced constipation.4
MOVANTIK is a prescription medicine used to treat constipation that is caused by prescription pain medicines called opioids, in adults with long-lasting (chronic) pain that is not caused by active cancer.5
MOVANTIK—one pill once a day—is specifically designed for OIC in adults with chronic non-cancer pain. It works by blocking opioids from binding to something called mu-receptors in your bowel.5
In clinical studies, MOVANTIK worked quickly, often within 6 to 12 hours of the first dose.5
MOVANTIK is a prescription medicine specifically for constipation from opioids in adults with chronic non-cancer pain.5
When starting MOVANTIK, changes to a patient's opioid dosing regimen are not required.5
MOVANTIK may cause serious side effects, including5:
Severe stomach pain or diarrhea, or both severe stomach pain and diarrhea.
Tear in your stomach or intestinal wall (perforation).
The most common side effects of MOVANTIK include: stomach (abdomen) pain, diarrhea, nausea, flatulence, vomiting, and headache.5
Patients should tell their healthcare provider if they have any side effect that bothers them or that does not go away. These are not all the possible side effects of MOVANTIK.
Patients should take MOVANTIK exactly as their health care provider prescribes. MOVANTIK should be taken 1 time each day, on an empty stomach, at least 1 hour before the first meal of the day or 2 hours after the meal. Patients should also stop taking other laxatives before they start treatment with MOVANTIK. A health care provider may prescribe other laxatives if MOVANTIK does not work after 3 days of treatment.5
Click here to see the MOVANTIK Prescribing Information.
The majority of commercial patients* nationwide are covered† for MOVANTIK. Patients can ask their pharmacist or insurance provider.6
With the MOVANTIK savings card, eligible patients pay as little as $0 per month for MOVANTIK.* That’s less than the cost of over-the-counter laxatives.†7
You may be eligible for this offer if you are insured by commercial insurance and your insurance does not cover the full cost of your prescription, or you are not insured and are responsible for the cost of your prescriptions.
Patients who are enrolled in a state or federally funded prescription insurance program are not eligible for this offer. This includes patients enrolled in Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD) programs or TriCare, and patients who are Medicare eligible and enrolled in an employer-sponsored group waiver health plan or government-subsidized prescription drug benefit program for retirees.
If you are enrolled in a state or federally funded prescription insurance program, you may not use this Savings Card even if you elect to be processed as an uninsured (cash-paying) patient.
This offer is not insurance and is restricted to residents of the United States and Puerto Rico and patients over 18 years of age. This offer is valid for retail prescriptions only.
Eligible commercially insured patients with a valid prescription for MOVANTIK® (naloxegol) tablets who present this Savings Card at participating pharmacies will pay $0 per 30-day supply, subject to a maximum savings of $100 per 30-day supply. Cash-paying patients will receive up to $100 in savings on out-of-pocket costs that exceed $0 per 30-day supply. This offer is good for 12 uses and each 30-day supply counts as 1 use. Other restrictions may apply. Patient is responsible for applicable taxes, if any. If you have any questions regarding this offer, please call 1-984-444-7010.
Offer expires on 12/31/2021.
Program managed by ConnectiveRx on behalf of RedHill Biopharma Inc.
MOVANTIK® (naloxegol) is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (eg, weekly) opioid dosage escalation.
You are encouraged to report Adverse Reactions to RedHill Biopharma Inc. at 1-833-ADRHILL (1-833-237-4455) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
RedHill Biopharma Inc. supports the responsible use of medications, including those containing opioids, as treatment options for patients with chronic non-cancer pain.
This site is intended for US health care professionals only.
RedHill Biopharma Inc. (U.S. Office)
8045 Arco Corporate Drive, Suite 200
Raleigh, NC 27617